KCNH5 c.2644C>T ;(p.R882*)

Variant ID: 14-63174549-G-A

NM_139318.4(KCNH5):c.2644C>T;(p.R882*)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.

Embo Molecular Medicine
Sorger, Helena H; Dey, Saptaswa S; Vieyra-Garcia, Pablo Augusto PA; Pölöske, Daniel D; Teufelberger, Andrea R AR; de Araujo, Elvin D ED; Sedighi, Abootaleb A; Graf, Ricarda R; Spiegl, Benjamin B; Lazzeri, Isaac I; Braun, Till T; Garces de Los Fayos Alonso, Ines I; Schlederer, Michaela M; Timelthaler, Gerald G; Kodajova, Petra P; Pirker, Christine C; Surbek, Marta M; Machtinger, Michael M; Graier, Thomas T; Perchthaler, Isabella I; Pan, Yi Y; Fink-Puches, Regina R; Cerroni, Lorenzo L; Ober, Jennifer J; Otte, Moritz M; Albrecht, Jana D JD; Tin, Gary G; Abdeldayem, Ayah A; Manaswiyoungkul, Pimyupa P; Olaoye, Olasunkanmi O OO; Metzelder, Martin L ML; Orlova, Anna A; Berger, Walter W; Wobser, Marion M; Nicolay, Jan P JP; André, Fiona F; Nguyen, Van Anh VA; Neubauer, Heidi A HA; Fleck, Roman R; Merkel, Olaf O; Herling, Marco M; Heitzer, Ellen E; Gunning, Patrick T PT; Kenner, Lukas L; Moriggl, Richard R; Wolf, Peter P
Publication Date: 2022-12-07

Variant appearance in text: KCNH5: R882X
PubMed Link: 36341492
Variant Present in the following documents:
  • EMMM-14-e15200-s004.xlsx, sheet 8
View BVdb publication page



Integrated molecular drivers coordinate biological and clinical states in melanoma.

Nature Genetics
Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM
Publication Date: 2020-12

Variant appearance in text: KCNH5: 2644C>T; R882*
PubMed Link: 33230298
Variant Present in the following documents:
  • NIHMS1637640-supplement-SuppData1.xlsx, sheet 1
View BVdb publication page



Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Nature Medicine
Liu, David D; Schilling, Bastian B; Liu, Derek D; Sucker, Antje A; Livingstone, Elisabeth E; Jerby-Arnon, Livnat L; Zimmer, Lisa L; Gutzmer, Ralf R; Satzger, Imke I; Loquai, Carmen C; Grabbe, Stephan S; Vokes, Natalie N; Margolis, Claire A CA; Conway, Jake J; He, Meng Xiao MX; Elmarakeby, Haitham H; Dietlein, Felix F; Miao, Diana D; Tracy, Adam A; Gogas, Helen H; Goldinger, Simone M SM; Utikal, Jochen J; Blank, Christian U CU; Rauschenberg, Ricarda R; von Bubnoff, Dagmar D; Krackhardt, Angela A; Weide, Benjamin B; Haferkamp, Sebastian S; Kiecker, Felix F; Izar, Ben B; Garraway, Levi L; Regev, Aviv A; Flaherty, Keith K; Paschen, Annette A; Van Allen, Eliezer M EM; Schadendorf, Dirk D
Publication Date: 2019-12

Variant appearance in text: KCNH5: 2644C>T
PubMed Link: 31792460
Variant Present in the following documents:
  • 41591_2019_654_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page